To ensure the cell and gene therapy field advances with all stakeholders in mind, especially the patient, we need to talk – now.

A rapid review of gene therapy’s rise – and a quick glimpse into the future.

How the EMA plans to help researchers and developers make better medicines.

Mark Jordi, President of Jordi Labs, discusses the latest in extractables and leachables science.

Since the beginning of the pandemic, the public has realized how essential the biotechnology industry is in securing our civilization's future.

What makes a good pharma employer? A survey asked over 7,000 people this question to determine the ingredients required for a positive work culture.

Additive manufacturing is so much more than just “cool” technology; it holds great promise for the biopharma industry.

As bioprocess technologies advance and drug markets evolve, new issues continually arise.

Platinum group (and other precious) metal catalysts are inherently expensive, so why not recover and recycle?

What have we learned from the pandemic and how can we address the coming challenges?